stocksbrew

Why Recursion Pharmaceuticals, Inc. (RXRX) Stock Fell 6.4% on Nov 17, 2026

as of Tuesday, 4:25 PM ET

The reason we found

JPMorgan cuts Recursion price target to $7

JPMorgan kept an Overweight rating but reduced its price target from $10 to $7, signaling lower expectations for Recursion’s valuation. That downgrade in the target can pressure shares, although the unchanged positive rating makes it a partial rather than definitive explanation for the 6.37% decline.

analyst price target cutmedium confidence

Sources 1

Weekend

Still Sunday. Nothing's moving except the clock.

1days01hrs13min43sec

Market opens Monday, Nov 23 at 9:30 AM ET